C. Jenkins (Sydney, Australia), K. Verhamme (Rotterdam, Netherlands), R. Gosens (Groningen, Netherlands), R. Rodríguez-Roisin (Barcelona, Spain)
Efficacy of fluticasone furoate (FF) and vilanterol (VI), separately and in combination (FF/VI), in an allergen challenge model
A. Oliver, L. Bjermer, D. Quinn, P. Saggu, P. Thomas, K. Yarnall, J. Lötvall (Uxbridge, United Kingdom; Lund, Sweden; Wellington, New Zealand; Sydney, Australia)
|  |
How frequent is bronchodilator reversibility in patients with stable asthma bronchiale and chronic obstructive lung disease (COPD) receiving maintenance therapy?
V. Muller, G. Galffy, M. Orosz, Z. Kovats, G. Losonczy, L. Tamasi (Budapest, Hungary)
|  |
Impact of age, age at diagnosis and duration of asthma on the risk of exacerbations in the EuroSMART study
R. Buhl, O. van Schayck, M. Aubier, J. Ostinelli, L. Jørgensen, J. Haughney (Mainz, Germany; Maastricht, Netherlands; Paris, Rueil Malmaison, France; Södertälje, Sweden; Aberdeen, United Kingdom)
| |
Patient and physician perspectives on asthma control and management strategies are discordant; a primary care survey in Canada
K.R. Chapman, J. Bouchard, R.M. Rea, G.W. Bishop (Toronto, La Malbaie, Mississauga, St. John, Canada)
| |
Halotherapy – A possible method to enhance airway treatment on patients with obstructive pathology
R. Crisan-Dabija, T. Mihaescu (Iasi, Romania)
| |
Safety and efficacy of ectoine inhalation solution in patients with inflammation and airway obstruction: The EFECT study
R. Berndt, U. Sydlik, A. Bilstein, A. Marini, T. Jaenicke, G. Seitner-Sorge, S. Stolz, J. Krutmann, U. Krämer, K. Unfried (Witten, Duesseldorf, Germany)
| |
Lebrikizumab reduces serum periostin in asthma patients with elevated baseline periostin
H. Scheerens, J. Arron, D. Choy, S. Mosesova, P. Lal, J. Matthews (San Francisco, United States Of America)
| |
Can roxithromycin improve quality of life in bronchiectatic patients?
P. Asintam, N. Kiranantawat, S. Juthong (HatYai, Thailand)
| |
An observational study assessing the practice of long-term azithromycin prescription in bronchiectasis
G. Hynes, C. Morgan, C. Sheldon, N. Withers (Exeter, United Kingdom)
| |
The p38 MAP kinase inhibitor dilmapimod ameliorates airway inflammation induced by ozone challenge in healthy volunteers
A. Kirsten, O. Holz, R. Tal-Singer, H. Magnussen, H. Watz (Grosshandorf, Hanover, Germany; King of Prussia, United States Of America)
| |
Effect of lidocaine and its delivery in chronic cough
R. Abdulqawi, J. Smith, R. Dockry, J. Oshodi, R. Murdoch, A. Woodcock (Manchester, London, United Kingdom)
| |
Bidirectional modulation of urge to cough by nasal TRPA1 and TRPM8 agonists in healthy human subjects
J. Plevkova, M. Brozmanova, S. Gavliakova, V. Calkovsky, I. Poliacek (Martin, Slovakia)
| |
A new rapid-onset dextromethorphan formulation for cough
C. Wright, R. Dickinson, R. Thompson, D. Hall, J.B. Morjaria, A. Morice (Hull, Egham, United Kingdom)
| |
Progressive case of recurrent respiratory papillomatosis successfully treated with gefitinib
V. Kolek, M. Hajduch, J. Kultan, L. Fajkosova (Olomouc, Czech Republic)
| |
Erdosteine – A new drug in the treatment of chronic rhinosinusitis
I. Stárek, J. Hoza, P. Schalek, R. Kellnerová (Olomouc, Praha, Brno, Czech Republic)
| |
A cross-sectional study examining inpatients‘ metered dose inhaler technique and the impact of assessment and education on its effective use
J. Jade, J. Lee, S.F. Hussain (Kettering, United Kingdom)
| |
Preference, satisfaction and critical errors with Genuair® and HandiHaler® in patients with COPD
J. van der Palen, T. Ginko, A. Kroker, P. van der Valk, M. Goosens, L. Padulles, B. Seoane, L. Rekeda, E. Garcia Gil (Enschede, Zutphen, Netherlands; Bonn, Koblenz, Germany; Barcelona, Spain; Jersey City, United States Of America)
| |
The effects of different inhaler devices on asthma control in patients with persistent asthma in Turkey
F. Yildiz, S. Akcali, N. Dursunoglu (Izmit/Kocaeli, Ankara, Denizli, Turkey)
| |
The asthmatic patient and inhaler treatment devices profile in Turkey: Asthma inhaler treatment study
F. Yildiz, N. Dursunoglu, S. Duru (Kocaeli, Denizli, Ankara, Turkey)
| |
Oxygen use and nasal symptoms
H. Meredith, A. Cran, M. Pipis, J. Goldring (London, United Kingdom)
| |